A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
Dayana Herrera-Rios(West Cancer Center), Ulf D. Kahlert(University Medical Center Freiburg)
Cited by 20
Related Papers
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
|Cell Death Discovery|2020|89
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
|Frontiers in Immunology|2020|38
Alterations in cellular metabolome after pharmacological inhibition of <scp>N</scp>otch in glioblastoma cells
|International Journal of Cancer|2015|37
Original article CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component
|Folia Neuropathologica|2012|31
The effect of neurosphere culture conditions on the cellular metabolism of glioma cells
|Folia Neuropathologica|2015|10